CorMedix (CRMD) Short Interest Ratio & Short Volume → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free CRMD Stock Alerts $5.25 -0.11 (-2.05%) (As of 05/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CorMedix Short Interest DataCurrent Short Interest9,680,000 sharesPrevious Short Interest9,860,000 sharesChange Vs. Previous Month-1.83%Dollar Volume Sold Short$50.82 millionShort Interest Ratio14.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares54,960,000 sharesPercentage of Shares Shorted17.61%Today's Trading Volume542,209 sharesAverage Trading Volume593,381 sharesToday's Volume Vs. Average91% Short Selling CorMedix ? Sign up to receive the latest short interest report for CorMedix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRMD Short Interest Over TimeCRMD Days to Cover Over TimeCRMD Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry CorMedix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20249,680,000 shares $50.82 million -1.8%N/A14.9 $5.25 4/30/20249,860,000 shares $51.81 million +5.1%N/A16.1 $5.26 4/15/20249,380,000 shares $50.46 million +13.7%N/A16 $5.38 3/31/20248,250,000 shares $34.98 million +6.2%N/A18.6 $4.24 3/15/20247,770,000 shares $29.60 million +0.7%N/A17.7 $3.81 2/29/20247,720,000 shares $27.33 million -0.1%N/A17.9 $3.54 Get the Latest News and Ratings for CRMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CorMedix and its competitors with MarketBeat's FREE daily newsletter. 2/15/20247,730,000 shares $25.28 million +7.5%N/A16.4 $3.27 1/31/20247,190,000 shares $21.21 million +2.0%N/A8.6 $2.95 1/15/20247,050,000 shares $24.46 million -0.6%N/A8.4 $3.47 12/31/20237,090,000 shares $26.66 million -1.5%N/A8.3 $3.76 12/15/20237,200,000 shares $23.83 million -8.1%N/A8.5 $3.31 11/30/20237,830,000 shares $25.45 million +17.6%N/A9.3 $3.25 11/15/20236,660,000 shares $22.18 million +17.1%N/A8.1 $3.33 10/31/20235,690,000 shares $19.80 million +11.4%N/A12.1 $3.48 10/15/20235,110,000 shares $17.07 million +3.0%N/A10.8 $3.34 9/30/20234,960,000 shares $18.35 million +6.4%N/A9.8 $3.70 9/15/20234,660,000 shares $18.22 million +15.4%N/A6.2 $3.91 8/31/20234,040,000 shares $16.44 million +0.3%N/A5.2 $4.07 8/15/20234,030,000 shares $17.17 million -7.6%N/A5.5 $4.26 7/31/20234,360,000 shares $19.27 million -16.3%N/A5.8 $4.42 7/15/20235,210,000 shares $20.27 million -0.2%N/A7.5 $3.89 6/30/20235,220,000 shares $20.70 million +71.7%N/A7.9 $3.97 6/15/20233,040,000 shares $15.72 million +16.0%N/A6.2 $5.17 5/31/20232,620,000 shares $12.60 million +20.7%N/A8.4 $4.81 5/15/20232,170,000 shares $11.18 million -2.3%N/A7 $5.15 4/30/20232,220,000 shares $10.97 million +8.3%N/A8.6 $4.94 4/15/20232,050,000 shares $10.80 million +3.0%N/A8.4 $5.27 3/31/20231,990,000 shares $8.24 million +19.2%N/A8.2 $4.14 3/15/20231,670,000 shares $5.90 million +4.4%N/A7.5 $3.53 2/28/20231,600,000 shares $6.48 million -0.6%N/A7.1 $4.05 2/15/20231,610,000 shares $7.23 million -3.0%N/A7.3 $4.49 1/31/20231,660,000 shares $7.20 million +1.2%N/A6.7 $4.34 1/15/20231,640,000 shares $7.27 million +6.5%N/A7 $4.43 12/30/20221,540,000 shares $6.50 million No ChangeN/A7.2 $4.22 12/15/20221,540,000 shares $6.38 million -1.3%N/A8 $4.14 11/30/20221,560,000 shares $6.49 million -4.9%N/A7.9 $4.16 11/15/20221,640,000 shares $6.05 million No ChangeN/A8.5 $3.69 10/31/20221,640,000 shares $5.03 million +5.1%N/A5.2 $3.07 10/15/20221,560,000 shares $4.60 million -5.5%N/A4.1 $2.95 9/30/20221,650,000 shares $4.67 million +1.9%N/A4 $2.83Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 9/15/20221,620,000 shares $5.65 million -5.3%N/A3.1 $3.49 8/31/20221,710,000 shares $6.04 million -5.0%N/A3.1 $3.53 7/30/20212,450,000 shares $0.00 +0.4%6.7%6.9 $0.00 7/15/20212,440,000 shares $0.00 -2.4%6.6%6.9 $0.00 6/30/20212,500,000 shares $0.00 -1.2%6.8%6.1 $0.00 6/15/20212,530,000 shares $0.00 -1.9%6.9%5.9 $0.00 5/28/20212,580,000 shares $0.00 -0.8%7.0%5.1 $0.00 5/14/20212,600,000 shares $0.00 +0.4%N/A2.8 $0.00 4/30/20212,590,000 shares $0.00 +2.8%N/A2.6 $0.00 4/15/20212,520,000 shares $20.49 million -4.2%N/A2 $8.13 3/31/20212,630,000 shares $22.59 million -4.4%N/A2.1 $8.59 3/15/20212,750,000 shares $25.77 million +4.2%N/A2.2 $9.37 2/26/20212,640,000 shares $22.97 million -0.8%N/A2.3 $8.70 2/12/20212,660,000 shares $20.46 million -15.0%N/A3.2 $7.69 1/29/20213,130,000 shares $51.74 million +3.0%N/A4.7 $16.53 1/15/20213,040,000 shares $42.86 million -0.3%N/A7.8 $14.10 12/31/20203,050,000 shares $22.54 million -1.3%N/A8.8 $7.39 12/15/20203,090,000 shares $24.97 million -5.8%N/A9 $8.08 11/30/20203,280,000 shares $29.39 million +9.3%N/A8.1 $8.96 11/15/20203,000,000 shares $17.07 million -3.5%N/A7.1 $5.69 10/30/20203,110,000 shares $15.89 million No ChangeN/A7.1 $5.11 10/15/20203,110,000 shares $18.26 million -12.9%N/A5.9 $5.87 9/30/20203,570,000 shares $21.53 million No ChangeN/A6.7 $6.03 9/15/20203,570,000 shares $16.31 million -4.8%N/A6.7 $4.57 8/31/20203,750,000 shares $17.51 million +3.0%N/A8.6 $4.67 8/14/20203,640,000 shares $15.83 million +15.2%N/A9.6 $4.35 7/31/20203,160,000 shares $14.06 million -24.0%N/A9.4 $4.45 7/15/20204,160,000 shares $24.04 million +27.6%N/A17 $5.78 6/30/20203,260,000 shares $20.11 million +1.9%N/A13.5 $6.17 6/15/20203,200,000 shares $19.01 million +6.7%N/A15.1 $5.94 5/29/20203,000,000 shares $13.83 million -16.9%N/A11.7 $4.61 5/15/20203,610,000 shares $13.65 million -0.6%N/A13.2 $3.78 4/30/20203,630,000 shares $15.86 million +0.3%N/A13.7 $4.37 4/15/20203,620,000 shares $13.79 million +0.6%N/A13.7 $3.81 3/31/20203,600,000 shares $15.70 million +0.1%N/A13 $4.36 3/13/20203,598,000 shares $12.84 million -4.1%N/A14.4 $3.57 2/28/20203,750,000 shares $10.39 million -2.9%N/A15 $2.77 2/14/20203,860,000 shares $21.89 million -4.5%N/A16.9 $5.67 1/31/20204,040,000 shares $22.62 million -0.7%N/A16.4 $5.60 1/15/20204,070,000 shares $25.97 million +1.0%N/A16.4 $6.38 12/31/20194,030,000 shares $27.44 million -1.0%17.0%16 $6.81 CRMD Short Interest - Frequently Asked Questions What is CorMedix's current short interest? Short interest is the volume of CorMedix shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 9,680,000 shares of CRMD short. Learn More on CorMedix's current short interest. What is a good short interest ratio for CorMedix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRMD shares currently have a short interest ratio of 15.0. Learn More on CorMedix's short interest ratio. Which institutional investors are shorting CorMedix? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CorMedix: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is CorMedix's short interest increasing or decreasing? CorMedix saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 9,680,000 shares, a drop of 1.8% from the previous total of 9,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CorMedix's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to CorMedix: Solid Biosciences Inc. (3.02%), Nature's Sunshine Products, Inc. (0.66%), Aquestive Therapeutics, Inc. (6.79%), Black Diamond Therapeutics, Inc. (3.80%), scPharmaceuticals Inc. (21.81%), OptiNose, Inc. (6.45%), DBV Technologies S.A. (0.27%), InflaRx (0.12%), Chimerix, Inc. (1.60%), Achilles Therapeutics plc (0.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short CorMedix stock? Short selling CRMD is an investing strategy that aims to generate trading profit from CorMedix as its price is falling. CRMD shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CorMedix? A short squeeze for CorMedix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRMD, which in turn drives the price of the stock up even further. How often is CorMedix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRMD, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SLDB Short Interest Data NATR Short Interest Data AQST Short Interest Data BDTX Short Interest Data SCPH Short Interest Data OPTN Short Interest Data DBVT Short Interest Data IFRX Short Interest Data CMRX Short Interest Data ACHL Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRMD) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.